| Thursday, September 4, 2008 |
Simcere announces interim results of Phase IV Endu trial
|
|
Ribbon cut on CBI's Venturepharm (Asia) Innovation Center
|
|
US Biotech Serenex faces IP nightmare scenario, China in the mix
Free
access
|
|
Hired gun will seek cash, weigh M&A options for Sinobiomed
|
|
NeoStem closes on USD 1.25 million, looks to China for growth
|
| Wednesday, September 3, 2008 |
|
Amended patent law submitted to congress, exceptions for health emergencies
|
|
If it sounds too good to be true... Taiyuan ADR cover-up suspected
Free
access
|
|
MOH reorg finalized, clarifies roles in hygiene and food safety
|
|
TCM maker Kangmei expands in Jilin, bags ginseng operation
|
|
Joincare reports RMB 400 million loss from stock trading
|
|
Bridge Laboratory GLP data accepted by FDA
Free
access
|
|
China Sky One to jump from AMEX to NASDAQ
|
| Tuesday, September 2, 2008 |
|
Soonfast receives China patents for anti-HPV/HSV herbal
Free
access
|
|
Accord among Accords: Shenzhen Accord Pharma buys Guangxi Accord Medicine
|
| Monday, September 1, 2008 |
|
Tianjin Tianyao pumps up steroid production, uses own new tech to cut costs
|
|
Sinopharm Medicine Holding to absorb Ningxia Medicine Business Group
|
| Friday, August 29, 2008 |
|
H2 slowdown predicted for China's pharmaceutical industry
Free
access
|
|
Large near and mid-term growth expected in China's hepatitis B market
|
|
Roche oral chemotherapeutic Xeloda granted SFDA approval
Free
access
|
| Thursday, August 28, 2008 |
|
Class action lawsuit turns up heat on Shenghuo
|
|
MicroPort acquires Pangrui, IPO still uncertain
|
|
Profex closes USD 15m finance round, Trident puts skin in the game
Free
access
|
|
Public to get a piece of Sinopharm in Q4? Details still unclear
|
| Wednesday, August 27, 2008 |
|
TCM = Targeting China Market? Buchang Group sticks to China for IPO
|
|
Nepstar CFO resigns
|